Intralytix Inc.
Columbia, MD
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 8681 Robert Fulton Dr, Columbia, MD 21046, USA
- Website
- intralytix.com
- Founded
- 1998
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $98,959 |
| FY2025 | $79,818 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of the Army | $98,959 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | P01AI195376 | $958,810 |
Similar vendors
About the company
Intralytix Inc. is a biotechnology company based in Columbia, Maryland, specializing in bacteriophage-based products for food safety, human, animal, and environmental health. Registered in SAM.gov since 2006, the company focuses on developing innovative biological solutions that leverage phage technology to address critical challenges in pathogen control and biosecurity. As a for-profit corporate entity, Intralytix has successfully secured federal contracts and grants that demonstrate its expertise in developing advanced microbiological technologies with applications in food processing, infectious disease management, and targeted pathogen reduction.
The company's federal contract awards reveal a sophisticated approach to research and development in biotechnology. Intralytix has been awarded two significant contracts: a $249,970 firm-fixed-price contract with the U.S. Army Combat Capabilities Development Command (CCDC) to optimize a dry formulation of PhageSafe phage preparation targeting foodborne bacterial pathogens, and a $1,797,717 Small Business Innovation Research (SBIR) Phase I contract from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a universal, AI-based platform for manufacturing high-titer biopharmaceuticals. Neither contract utilized a set-aside designation, and both focus on advanced technological solutions with potential broad applications in medical and food safety domains.
Intralytix's federal grant awards further underscore its commitment to innovative food safety solutions. A notable two-year, $999,824 project grant from the USDA National Institute of Food and Agriculture supported the company's efforts to optimize its Salmonella-targeting phage product SalmoFresh in poultry processing facilities. The grant, part of the American Rescue Plan Centers of Excellence for Meat and Poultry Processing and Food Safety Research and Innovation Phase III program, aimed to design a customized spray system for phage application and improve Salmonella reduction methods. Another grant from the Institute of Food Safety and Nutrition focused on phage biocontrol of Vibrio parahaemolyticus for enhancing seafood safety, demonstrating Intralytix's broad approach to pathogen control across different food production environments.
Quick answers
Is Intralytix Inc. registered in SAM.gov?
Yes. Intralytix Inc.'s SAM.gov registration is active through May 21, 2027.
What is Intralytix Inc.'s CAGE code?
Intralytix Inc.'s CAGE code is 4GXB8, and its Unique Entity ID (UEI) is HXUNCLKMHAP4.
How much has Intralytix Inc. received in federal contracts?
Federal contracts obligated $79,818 to Intralytix Inc. in fiscal year 2025 and $178,777 in fiscal years 2023 through 2027.
What is Intralytix Inc.'s most recent federal award?
Intralytix Inc.'s most recent federal contract award is Broad agency announcement to have stable dry formulation of a safe phage preparation that possesses strong… (W911QY25C0015), from ACC Aberdeen Proving Ground, on February 13, 2025.
On GovTribe
See Intralytix Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors